Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361
Author
Powles, T. B.
Rodriguez-Vida, A.
Mamtani, R.
Yu, E. Y.
Nam, K.
Imai, K.
Moreno, B. H.
Alva, A.
Csoszi, T.
ÖZGÜROĞLU, Mustafa
Matsubara, N.
Geczi, L.
Cheng, S. Y-S.
Fradet, Y.
Oudard, S.
Vulsteke, C.
Morales Barrera, R.
Flechon, A.
Gunduz, S.
Loriot, Y.
Metadata
Show full item recordCollections
- Bildiri [64839]